固形組成物 - Taisho Pharmaceutical Co., Ltd.

Title:

固形組成物

Document Type and Number:

Japanese Patent JP7472540

Kind Code:

B2

Abstract:

To provide a solid composition which suppresses the decrease in the content of loratadine with time even if containing ibuprofen and loratadine.SOLUTION: There is provided a solid composition which comprises (a) ibuprofen and (b) loratadine and further (c) at least one selected from the group consisting of carbocisteine, ambroxol and its salt, bromhexine and its salt, tranexamic acid, glycyrrhizic acid and its salt, tipepidine and its salt and dextromethorphan and its salt.SELECTED DRAWING: None

More Like This:

JP6589246	SSAO inhibitor derived from imidazole [4,5-C] pyridine
JP2021508703	IRAK Degradants and Their Use
JP6101290	Substitution phenyl imidazo Pyrazole and its use

Inventors:

Yuko Shiga
East treetop

Application Number:

JP2020032543A

Publication Date:

April 23, 2024

Filing Date:

February 28, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Taisho Pharmaceutical Co., Ltd.

International Classes:

A61K31/4545; A61K9/14; A61K9/16; A61K9/20; A61K9/48; A61K31/192; A61K31/198; A61P29/00; A61P43/00

Domestic Patent References:

JP2008143807A
JP201890572A
JP200696749A

Previous Patent: Image forming device

Next Patent: Color estimation device, color estimation method and program